The Flint, Michigan water crisis is making waves yet again as a recent study shows how Lead in the water caused numerous fetuses to die and the birth rate to decline in the area. This is a problem that researchers have been warning both local and federal officials about but has largely been ignored in practically every level of government. It wasn’t until they were forced to confront the truth was action taken to remedy the situation.
The study was conducted and published by Daniel Grossman and David Slusky from West Virginia University and the University of Kansas, respectively. According to their findings, the high levels of lead in the water led to a significant increase in fetal deaths in the city of up to 58 percent.
“Exploiting variation in the timing of births we find fertility rates decreased by 12%, fetal death rates increased by 58% (a selection effect from a culling of the least healthy fetuses), and overall health at birth decreased (from scarring), compared to other cities in Michigan. Given recent efforts to establish a registry of residents exposed, these results suggests women who miscarried, had a stillbirth or had a newborn with health complications should register,” the paper reads.
Grossman and Slusky further clarified that an estimated 198 to 276 fetal deaths can be directly attributed to the high levels of toxic metal in Flint’s water supply, Huffington Post reports. The study supports the assertions that other researchers have been saying since 2014, and which Michigan Gov. Rick Snyder (R), as well as state government officials, ignored.
Several of the people responsible for this tragedy have since been criminally indicted and charged with manslaughter, but they only go up to a certain level. Federal officials who ignored the issue were never even grazed. Perhaps the reality of hundreds of dead fetuses will finally lead to the delivery of real justice.


SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
FDA Weighs Safety Standards for Psychedelic Therapies
Tabletop particle accelerator could transform medicine and materials science
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
3 clinical-grade skincare creams you really shouldn’t buy online
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Trump Administration Releases New UFO Files and Apollo Mission Records
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
U.S. Issues Cuba Health Alert as Illnesses Rise 



